Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov;181(21):4103-4116.
doi: 10.1111/bph.16104. Epub 2023 Jun 1.

The importance of binding kinetics and drug-target residence time in pharmacology

Kevin E Knockenhauer  1 , Robert A Copeland  1
Affiliations
Review

The importance of binding kinetics and drug-target residence time in pharmacology

Kevin E Knockenhauer et al. Br J Pharmacol. 2024 Nov.

Abstract

A dominant assumption in pharmacology throughout the 20th century has been that in vivo target occupancy-and attendant pharmacodynamics-depends on the systemic concentration of drug relative to the equilibrium dissociation constant for the drug-target complex. In turn, the duration of pharmacodynamics is temporally linked to the systemic pharmacokinetics of the drug. Yet, there are many examples of drugs for which pharmacodynamic effect endures long after the systemic concentration of a drug has waned to (equilibrium) insignificant levels. To reconcile such data, the drug-target residence time model was formulated, positing that it is the lifetime (or residence time) of the binary drug-target complex, and not its equilibrium affinity per se, that determines the extent and duration of drug pharmacodynamics. Here, we review this model, its evolution over time, and its applications to natural ligand-macromolecule biology and synthetic drug-target pharmacology.

Keywords: PK–PD relationships; binding kinetics; drug optimization; drug–target residence time.

PubMed Disclaimer

References

REFERENCES

    1. Akhunzada, M. J., Yoon, H. J., Deb, I., Braka, A., & Wu, S. (2022). Bell‐Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands targeting G‐protein‐coupled receptors. Scientific Reports, 12, 15972. https://doi.org/10.1038/s41598-022-20065-2
    1. Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., & Pawson, A. J. (2021). The concise guide to pharmacology 2021/22: G protein‐coupled receptors. British Journal of Pharmacology, 176(Suppl 1), S27–S156.
    1. Alexander, S. P., Cidlowski, J. A., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Davies, J. A., Coons, L., Fuller, P. J., Korach, K. S., & Young, M. J. (2021). The concise guide to pharmacology 2021/22: Enzymes. British Journal of Pharmacology, 178(Suppl 1), S313–S411. https://doi.org/10.1111/bph.15540
    1. Alexander, S. P., Fabbro, D., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., & Southan, C. (2021). The concise guide to pharmacology 2021/22: Catalytic receptors. British Journal of Pharmacology, 178(Suppl 1), S264–S312. https://doi.org/10.1111/bph.15541
    1. Alexander, S. P., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Buneman, O. P., Cidlowski, J. A., Christopoulos, A., Davenport, A. P., Fabbro, D., Spedding, M., Striessnig, J., Davies, J. A., Ahlers‐Dannen, K. E., … Zolghadri, Y. (2021). The concise guide to pharmacology 2021/22: Introduction and other protein targets. British Journal of Pharmacology, 178(Suppl 1), S1–S26. https://doi.org/10.1111/bph.15537

LinkOut - more resources